{"summary":"I am keenly interested in answering critical questions surrounding protein higher-order structure (HOS) in biotherapeutics. Especially with a focus on addressing challenges during the preclinical and clinical development of pharmaceutics including drug stability, formulation, and process development. Expertly trained in the analysis of the structure-function relationship of therapeutic proteins using hydrogen exchange-mass spectrometry (HX-MS). Proficient in developing LC-MS based host-cell proteomic methods and workflows to support process development. Well-experienced in the development and validation of LC-MS methods for bioanalysis of drug metabolites in preclinical and clinical studies under GLP conditions.\n\nI am seeking opportunities as a research scientist within the pharmaceutical industry, where I can apply my experience and expertise. Let's connect!","lastName":"Karunaratne","objectUrn":"urn:li:member:274525970","geoRegion":"Lawrence, Kansas, United States","fullName":"Sachini Karunaratne","firstName":"Sachini","currentPositions":[{"companyName":"The University of Kansas Cancer Center","description":"\u2022 Development and validation of LC-MS\/MS bioanalytical methods for quantitation of small molecule therapeutic agents and biomarkers, contributing to six successful clinical and preclinical studies.\n\u2022 Conducting bioanalytical sample preparation (calibration standards, spiking solutions) in compliance with GLP and GCP settings, with experience in handling biological matrices. Trained on the Waters Andrew+ pipetting robot for sample preparation.\n\u2022 Investigating non-specific binding of drugs by employing methods such as ultracentrifugation, Rapid Equilibrium Dialysis (RED) devices, and centrifugal filtering devices (Amicon, Centrifree).\n\u2022 Daily operation, troubleshooting, and maintenance of LC-MS systems, including the Waters Acquity UPLC I-class, Waters Xevo TQ-S, Waters Xevo Absolute, and using MassLynx for analysis.","title":"Senior Laboratory Coordinator","companyUrnResolutionResult":{"employeeCountRange":"1001-5000","headquarters":{"geographicArea":"KS","country":"United States","city":"Kansas City","postalCode":"66160","line2":"Mailstop 1027","line1":"3901 Rainbow Blvd."},"website":"http:\/\/www.kucancercenter.org\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/the-university-of-kansas-cancer-center\/","industry":"Hospitals and Health Care"},"companyUrn":"urn:li:fs_salesCompany:547375","tenureAtCompany":{"numMonths":10},"startedOn":{"month":8,"year":2023}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1614923192245?e=1723075200&v=beta&t=8FaVxWjgBaO-VgcZR0jt5AlLldn7jtXcSEXgH-lxZTc","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1614923192245?e=1723075200&v=beta&t=BOkaXC8y7ozPVvZO1iTvcsa-8HAvti_RZ66HiBDDHto","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1614923192245?e=1723075200&v=beta&t=fXkNYXNBF2pnKaMMM7yx9xJFSUCvgKLNQHDx0OI2p1c","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1614923192245?e=1723075200&v=beta&t=gIrroQohkoZYTHI6dH0-RrlfFMtQvuOFGYKwmMWtiJ8","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4E03AQHmJrq076iU-g\/profile-displayphoto-shrink_"},"projects":[{"endedOn":{"month":8,"year":2021},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)"}],"title":"Understanding effects of linker-drug conjugation on antibody drug conjugate structure using hydrogen exchange-mass spectrometry (HX-MS)","startedOn":{"month":1,"year":2021}},{"endedOn":{"month":6,"year":2022},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)"}],"title":"Investigating preservative-protein interactions to support multi-dose formulation development for biologics","startedOn":{"month":9,"year":2021}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)"}],"title":"Comparative analysis of LC-MS based workflows for host cell protein analysis in process development ","startedOn":{"month":7,"year":2022}}],"contactInfo":{},"industry":"Pharmaceutical Manufacturing","educations":[{"endedOn":{"year":2024},"degree":"Doctor of Philosophy - PhD","eduId":877107105,"schoolUrn":"urn:li:fs_salesSchool:166643","school":"urn:li:fs_salesSchool:166643","fieldsOfStudy":["Chemistry"],"schoolName":"The University of Kansas","startedOn":{"year":2019}},{"endedOn":{"year":2017},"degree":"Bachelor of Science (B.Sc.)","eduId":378209721,"schoolUrn":"urn:li:fs_salesSchool:250357","school":"urn:li:fs_salesSchool:250357","fieldsOfStudy":["Chemistry"],"schoolName":"University of Peradeniya","startedOn":{"year":2014}},{"endedOn":{"year":2014},"eduId":170709280,"schoolUrn":"urn:li:fs_salesSchool:163045","school":"urn:li:fs_salesSchool:163045","fieldsOfStudy":["Accounting and Business\/Management"],"schoolName":"CIMA","startedOn":{"year":2012}}],"skills":[{"numOfEndorsement":1,"name":"Mass Spectrometry"},{"numOfEndorsement":1,"name":"High-Performance Liquid Chromatography (HPLC)"},{"numOfEndorsement":1,"name":"Proteomics"},{"numOfEndorsement":1,"name":"Liquid Chromatography-Mass Spectrometry (LC-MS)"},{"numOfEndorsement":1,"name":"Hydrogen Exchange Mass Spectrometry"},{"numOfEndorsement":1,"name":"Peptide Mapping"},{"numOfEndorsement":0,"name":"Analytical Chemistry"},{"numOfEndorsement":0,"name":"Biologics"},{"numOfEndorsement":0,"name":"Protein Expression"},{"numOfEndorsement":0,"name":"Protein Purification"},{"numOfEndorsement":0,"name":"Differential Scanning Calorimetry (DSC)"},{"numOfEndorsement":0,"name":"ELISA"},{"numOfEndorsement":0,"name":"SDS-PAGE"},{"numOfEndorsement":0,"name":"HX Data Analysis"}],"numOfConnections":561,"patents":[],"headline":"Mass spectrometry | HX-MS | Proteomics ","courses":[{"name":"Advanced Topics in Chemistry (Biomedical Devices)"},{"name":"Mass Spectrometry"},{"name":"Introduction to Chemistry in Biology"},{"name":"Fundamental methods in Analytical Chemistry"},{"name":"Lab safety in Chemical Science"},{"name":"Responsible Scholarship in Chemical Science"},{"name":"Analytical Separations"},{"name":"Modern Biochemical and Biophysical methods"}],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/sachini-karunaratne","organizations":[{"name":"American Society of Mass Spectrometry","position":"Student","startedOn":{"month":1,"year":2021}},{"name":"International society of HDX-MS","position":"Member","startedOn":{"month":1,"year":2021}},{"name":"American Association of Pharmaceutical Sciences ","startedOn":{"month":6,"year":2023}}],"location":"Lawrence, Kansas, United States","publications":[{"publishedOn":{"month":12,"day":15,"year":2023},"description":"Multidose formulations have patient-centric advantages over single-dose formats. A major challenge in developing multidose formulations is the prevention of microbial growth that can potentially be introduced during multiple drawings. The incorporation of antimicrobial preservatives (APs) is a common approach to inhibit this microbial growth. Selection of the right preservative while maintaining drug product stability is often challenging. We explored the effects of three APs, 1.1 % (w\/v) benzyl alcohol, 0.62 % (w\/v) phenol, and 0.42 % (w\/v) m-cresol, on a model immunoglobulin G1 monoclonal antibody, termed the \"NIST mAb.\" As measured by hydrogen exchange-mass spectrometry (HX-MS) and differential scanning calorimetry, conformational stability was decreased in the presence of APs. Specifically, flexibility (faster HX) was significantly increased in the CH2 domain (HC 238-255) across all APs. The addition of phenol caused the greatest conformational destabilization, followed by m-cresol and benzyl alcohol. Storage stability studies conducted by subvisible particle (SVP) analysis at 40 \u00b0C over 4 weeks further revealed an increase in SVPs in the presence of phenol and m-cresol but not in the presence of benzyl alcohol. However, as monitored by size exclusion chromatography, there was neither a significant change in the monomeric content nor an accumulation of soluble aggregate in the presence of APs.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/37967687\/","name":"Interaction between preservatives and a monoclonal antibody in support of multidose formulation development","publisher":"International Journal of Pharmaceutics","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)"}]},{"publishedOn":{"month":1,"day":18,"year":2024},"description":"Hydrogen exchange-mass spectrometry (HX-MS) is a valuable analytical technique that can provide insight into protein interactions and structure. The deuterium labeling necessary to gain this insight is affected by many physical and chemical factors, making it challenging to achieve high reproducibility. Poor precision during dispensing, transfer, and mixing of solutions during the experiment contributes substantially to the overall variability. While the use of a robotic liquid handler can potentially improve precision, its operation must be optimized. We observed poor precision in data collected using a robotic liquid handler to perform HX-MS. In this work, we describe how we were able to improve that system\u2019s precision considerably based on tracking performance using caffeine, caffeine-d3, and caffeine-d9 as tracers for the sample, label, and quench to report on each operation of the liquid handling workflow. The insights gained about liquid handler performance and the three-tracer approach can aid in optimizing HX-MS workflow operations, whether performed manually or when using a liquid handling system. Additionally, these tracers can be incorporated as internal tracers during an experiment to report on the labeling and quench operations of each sample throughout the run and, if desired, be used to implement an uptake correction described previously.","url":"https:\/\/pubs.acs.org\/doi\/epdf\/10.1021\/acs.analchem.3c04186","name":"Optimization of a Hydrogen Exchange-Mass Spectrometry Robotic Liquid Handler Using Tracers","publisher":"Analytical Chemistry","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABBc7xIBO7Ax7Kc8qKyesufojbx8FOsBQiU,NAME_SEARCH,rOAX)"}]}],"positions":null,"posts":[{"createdAt":1715967360000,"insightId":"2229ae8f-2829-4bff-a646-4e3a079301c3","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D5627AQHQykJBWNZLCQ\/articleshare-shrink_800\/0\/1715967187530?e=1717977600&v=beta&t=tGOS3OAn3GG9tUR7-vL_up3Sm-2YATp013WiZFkXygE","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D5627AQHQykJBWNZLCQ\/articleshare-shrink_800\/0\/1715967187530?e=1717977600&v=beta&t=tGOS3OAn3GG9tUR7-vL_up3Sm-2YATp013WiZFkXygE"}]},"description":"Antibody drug conjugates (ADCs) represent one of the fastest growing classes of cancer therapeutics. Drug incorporation through site-specific conjugat\u2026","resolvedUrl":"https:\/\/doi.org\/10.1016\/j.xphs.2024.05.008","title":"Understanding the effects of site-specific light chain conjugation on antibody structure using hydrogen exchange-mass spectrometry (HX-MS)"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":45},{"type":"PRAISE","count":27},{"type":"EMPATHY","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7197288958832099328","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":76,"commentsCount":32,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7197288956785278979","message":{"attributes":[{"length":6,"start":967,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1304385"}}},{"length":17,"start":1006,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:303934982"}}},{"length":11,"start":1028,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:53893452"}}},{"length":24,"start":1138,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/gRYx6hVM"}}}],"text":"Excited to share one of my dissertation chapters on Antibody Drug Conjugates, published in the Journal of Pharmaceutical Sciences. \n\nThe targeted delivery of cytotoxic drugs via conjugation to antibodies is a rapidly-expanding class of drugs. The combination of a small molecule with an antibody has a multiplicative effect on the challenges encountered in physical stability. In this study, we used differential HX-MS to explore the impact of drug conjugation on the conformational stability and structural dynamics of a\u00a0mAb. A side-by-side comparison between a mAb conjugated with a pyrrolobenzodiazepine drug and an unconjugated mAb revealed subtle conformational changes induced by the linker-drug, particularly near the site of conjugation and at distant sites. To gain a comprehensive understanding of these effects, various complementary biophysical techniques (DSC, DSF, SEC, and icIEF) were integrated into the study.\n\nIt\u00a0was a privilege\u00a0to collaborate with AbbVie on this project. Many thanks to Brittney J. Mills and Ehab Moussa from AbbVie and my PhD advisor, David Weis, for their continuous support throughout the project.\n\nhttps:\/\/lnkd.in\/gRYx6hVM"},"entityUrn":"urn:li:share:7197288956785278979"}}},{"createdAt":1717162620000,"insightId":"80658ae6-8bfa-48d0-82aa-e5d2f11d74b7","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7202302048980131840)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:494754481"}}}],"text":"Nimesha Devindi Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1717162620000,"insightId":"d8ba4935-87d0-4346-8bb7-8232b2223e98","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7202302179284508673)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":20,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:613630875"}}}],"text":"Prarthana Abeysinghe Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1717162620000,"insightId":"9f2594ce-8da4-4894-8a8b-2c7f58f769d9","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7202302107419303936)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:97369960"}}}],"text":"Chamani Perera Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249240000,"insightId":"b453392b-1c6a-4616-93a5-18b37a1841e0","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198471171695075328)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249240000,"insightId":"d3d9f107-e5c2-4388-897e-dfd27855629b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198471115462119424)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249240000,"insightId":"70195588-a0bc-4e15-8fd5-51f3e7de8b03","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198471076190801920)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"fae83b42-5b25-458b-9162-8b4844664966","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470830819844096)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"efedd208-10ac-4ec9-815c-e8cdb123dda7","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470913741242368)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"db78383a-b2e2-44fe-a55a-82870473226a","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470870615404544)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"13abec46-2b2a-4dc6-9c1a-69a9b183e2e6","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470987556741120)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"5b6565f3-9aa9-429f-b40b-b597a150ef00","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198471026828038144)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249180000,"insightId":"f15371a5-2c99-4eb0-ba73-9a9b15508f09","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470954656677889)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249120000,"insightId":"93814c21-af24-4213-8586-7c11bf0db8a7","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470710275497985)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249120000,"insightId":"7d72f3d5-e190-4b1f-8aeb-ffbf2831cae2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470655338504193)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1716249120000,"insightId":"f200135a-97f0-4811-a854-49fcd0f1e636","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7197288958832099328,7198470767540330496)","threadUrn":"urn:li:activity:7197288958832099328","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7197288958832099328"}}},{"createdAt":1715980140000,"insightId":"5b3cbe87-9089-4db0-aa82-f50662e54323","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7197225138650533890,7197342475777163264)","threadUrn":"urn:li:ugcPost:7197225138650533890","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":10,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:330755211"}}}],"text":"Halei Zhai Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7197225138650533890"}}},{"createdAt":1715962680000,"insightId":"a1e8ad0f-fc55-4aee-9466-aada4abd53aa","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7197225138650533890,7197269283058454528)","threadUrn":"urn:li:ugcPost:7197225138650533890","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Thank you so much for sharing this!\n"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7197225138650533890"}}},{"createdAt":1714918440000,"insightId":"b969e6d9-b9e3-4c1f-85ae-ff3c4fdad4fa","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7192720689672421376,7192889502707679232)","threadUrn":"urn:li:ugcPost:7192720689672421376","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Prabhavie! \ud83c\udf89\ud83c\udf89"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7192720689672421376"}}},{"createdAt":1714876980000,"insightId":"69313806-7d12-4edc-b695-aeaa70777ad6","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7192668937443024896,7192715546998530048)","threadUrn":"urn:li:ugcPost:7192668937443024896","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Miyuru! \ud83c\udf89\ud83c\udf89"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7192668937443024896"}}}]}